Peer-reviewed veterinary case report
Dogs have 3 years immunity after canine parvovirus and adenovirus
By Larson, L J & Schultz, R D·Published in Veterinary therapeutics : research in applied veterinary medicine·2007·Department of Pathological Sciences, United States·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Three-year serologic immunity against canine parvovirus type 2 and canine adenovirus type 2 in dogs vaccinated with a canine combination vaccine.
- Species:
- dog
Plain-English summary
A group of dogs was tested to see how long their vaccinations against canine parvovirus (CPV-2) and canine adenovirus (CAV-1) would protect them. After receiving a combination vaccine, the dogs showed strong immunity for at least three years. This means that pet owners can safely vaccinate their dogs every three years, ensuring they remain protected against these serious viruses. Regular vaccinations help keep dogs healthy and prevent outbreaks of these diseases.
People also search for: dog parvovirus vaccine duration · how often should dogs be vaccinated · canine adenovirus vaccine schedule
Abstract
A group of client-owned dogs and a group of dogs at a commercial kennel were evaluated for duration of antibody responses against canine parvovirus type 2 (CPV-2) and canine adenovirus type 1 (CAV-1) after receiving a combination vaccine containing recombinant canarypox-vectored canine distemper virus (CDV) and modified-live CPV-2, CAV-2, and canine parainfluenza virus, with (C6) or without (C4) two serovars of Leptospira (Recombitek C4 or C6, Merial). Duration of antibody, which correlates with protective immunity, was found to be at least 36 months in both groups. Recombitek combination vaccines can confidently be given every 3 years with assurance of protection in immunocompetent dogs against CPV-2 and CAV-1 as well as CDV. This allows this combination vaccine, like other, similar modified- live virus combination products containing CDV, CAV-2, and CPV-2, to be administered in accordance with the recommendations of the American Animal Hospital Association Canine Vaccine Task Force.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/18183549/